Compositions and methods for minimizing or reducing agonist-induced desensitization
AssigneePharmorx Inc.
InventorsDavid M. Bear, Robert M. Kessler
Life of this patent
Estimating the term…
Loading patent…
AssigneePharmorx Inc.
InventorsDavid M. Bear, Robert M. Kessler
Estimating the term…
Methods and compositions are provided for preventing or reversing loss of the therapeutic effect of a drug, where the loss is associated with the repeated administration of the drug to a patient. The method includes administering to the patient a dopamine receptor agonist or partial agonist or a drug that increases the extracellular level of dopamine by enhancing release of dopamine, decreasing the removal of dopamine from the extracellular space, enhancing the synthesis of dopamine within the brain, or decreasing metabolic degradation of dopamine; and also administering to the patient an opioid receptor antagonist in an ultra-low dose amount, wherein the ultra-low dose amount is effective to prevent or reverse loss of therapeutic effects associated with the repeated administration of the drug to the patient. The methods are useful for various treatments, including treating Parkinson's Disease, Restless Leg Syndrome, depression, schizophrenia, psychostimulant drug abuse, or attention deficit disorder.
A method for preventing or reversing loss of the therapeutic effect of a dopamine receptor agonist or partial agonist associated with the repeated administration of the dopamine receptor agonist or partial agonist to a patient comprising:
A method for preventing or reversing loss of the therapeutic effect of a drug associated with the repeated administration of the drug to a patient comprising:
A pharmaceutical formulation comprising:
A method for treating Restless Leg Syndrome, Parkinson's Disease, or another dopamine-related movement disorder in a patient comprising:
A method for treating Restless Leg Syndrome (RLS) in a patient comprising:
A method for treating Parkinson's Disease in a patient comprising:
A method for treating depression in a patient comprising:
A method for treating schizophrenia in a patient comprising:
A method for treating psychostimulant abuse in a patient comprising:
A method for treating attention deficit hyperactivity disorder (ADHD) in a patient comprising:
A method for treating a dopamine deficiency disease or condition in a patient comprising:
A method for the treatment of pituitary adenomas in a patient, comprising:
A method of treatment comprising:
Dependencies are inferred from the claim text.